Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,304 warrant series at 1,050 companies. 774 in the money, 59 expiring in the next 30 days, 34 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 Pre-Funded Warrants ($0.0001, May 7, 2024 underwritten offering) | $2.60 | $160.0M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants issued as part of the 2021 public offering ($9.75, exp. December 21, 2026) | $2.60 | $160.0M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants issued as part of the 2022 Private Placement Offering ($4.75, exp. November 3, 2027) | $2.60 | $160.0M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants issued as part of the 2024 Loan Agreement (January Warrants, $4.07, exp. January 8, 2029) | $2.60 | $160.0M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants issued as part of the 2024 Loan Agreement Amendment (July 2025 Avenue Warrants, $6.07, exp. July 18, 2030) | $2.60 | $160.0M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Legacy warrants outstanding prior to the PIPE (pre-August 2025) | $2.84 | $159.0M | S-3ASR, Aug 8, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| PIPE Pre-Funded Warrants (August 7, 2025) | $2.84 | $159.0M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| BSA 2017 (share subscription warrants, Board members) | $1.36 | $156.8M | 6-K EX-99.2, Sep 17, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| BSA 2022-1 (share subscription warrants, Board members) | $1.36 | $156.8M | 6-K EX-99.2, Sep 17, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| BSA 2023-1 (share subscription warrants, Board members) | $1.36 | $156.8M | 6-K EX-99.2, Sep 17, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| BSA 2025-1 (share subscription warrants, Board members) | $1.36 | $156.8M | 6-K EX-99.2, Sep 17, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Finders' warrants – September 16, 2025 brokered private placement ($3.30, expiring September 16, 2027) | $2.22 | $156.4M | 6-K EX-99.1, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Common Inducement Warrants ($4.00, February 2025) | $0.6783 | $154.0M | 10-Q, Aug 19, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Placement Agent Inducement Warrants ($5.00, March 2025) | $0.6783 | $154.0M | 10-Q, Aug 19, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Placement Agent Warrants ($1.69, September 2024) | $0.6783 | $154.0M | 10-Q, Aug 19, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Public Offering Warrants ($1.35, September 2024) | $0.6783 | $154.0M | 10-Q, Aug 19, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Representative’s Warrants (IPO, $6.00) | $0.6783 | $154.0M | 10-Q, Aug 19, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Pre-funded warrants – June 18, 2026 registered direct offering | $3.27 | $153.0M | 424B5, Jun 17, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Underwriter warrants (Titan) – Aug/Sep 2025 offerings, $7.20 | $3.27 | $153.0M | 10-K, Mar 31, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Underwriter warrants (Titan) – March 2, 2026 offering, $9.00 | $3.27 | $153.0M | 10-Q, Aug 19, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| JPMC Warrant (August 14, 2025) | $5.96 | $151.6M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Public Warrants (included in IPO Units) | $10.08 | $151.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Sponsor Private Placement Warrants | $10.08 | $151.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Underwriter Private Placement Warrants | $10.08 | $151.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| 2023 Warrant (Warrant No. W-004) | $4.61 | $151.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Replacement 2020 Warrant (Warrant No. W-005, amended and restated) | $4.61 | $151.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Replacement 2021 Warrant (Warrant No. W-006, amended and restated) | $4.61 | $151.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Replacement 2022 Warrant (Warrant No. W-007, amended and restated) | $4.61 | $151.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Augusta Lender Warrants (C$0.63, expiring November 1, 2028) | $1.50 | $149.0M | 40-F EX-99.1, Mar 19, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Class A Warrants (US$3.04, expiring February 4, 2029) | $1.50 | $149.0M | 6-K EX-99.1, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Class B Warrants (US$3.71, expiring February 4, 2029) | $1.50 | $149.0M | 6-K EX-99.1, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| 2024 Concurrent Private Placement Warrants (Insider Warrants) | $2.88 | $148.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2025 Placement Agent Warrants ($3.00, issued 2025-09-05) | $2.49 | $146.9M | 10-K, Apr 15, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| February 2026 Placement Agent Warrants ($15.00, issued 2026-02-05) | $2.49 | $146.9M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants to purchase common stock (aggregate; Oxford Finance LLC / Silicon Valley Bank loan warrants per exhibit list) | $8.78 | $145.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| April 2024 Pre-Funded Warrants | $2.29 | $143.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| December 2024 Pre-Funded Warrants | $2.29 | $143.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Legacy Humacyte Common Stock Warrants (SVB lenders) | $0.5104 | $142.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Loan Agreement Warrants (Avenue) — base exercise value | $0.5104 | $142.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| November 2024 RDO Warrants (1,640-day tranche) | $0.5104 | $142.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| October 2024 RDO Warrants (1,640-day tranche) | $0.5104 | $142.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| October 2025 RDO Warrants | $0.5104 | $142.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Other warrants (service agreement, May 27, 2026) | $0.5104 | $142.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Unit Purchase Option (Chardan) - 115,000 Option Units | $0.8099 | $141.9M | 20-F, Apr 28, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Warrants assumed from Arisz Acquisition Corp. (public and private warrants; Nasdaq: FUFUW) | $0.8099 | $141.9M | 20-F, Apr 28, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| August 2024 Private Placement Series A Warrants ($1.00, Group A units) | $0.9701 | $141.0M | S-3, May 30, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| CEO warrants granted 01/04/2025 ($0.99, Melsert) | $0.9701 | $141.0M | DEF 14A, Sep 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| CEO warrants granted 02/26/2024 ($4.33, Melsert) | $0.9701 | $141.0M | DEF 14A, Sep 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| CEO warrants granted 04/06/2024 ($4.33, Melsert) | $0.9701 | $141.0M | DEF 14A, Sep 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| CEO warrants granted 10/04/2024 ($4.33, Melsert) | $0.9701 | $141.0M | DEF 14A, Sep 22, 2026Dilution tabAs of Nov 13, 2026 |
ABEOAbeona Therapeutics Inc.$2.60Last price
2024 Pre-Funded Warrants ($0.0001, May 7, 2024 underwritten offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$160.0M
ABEOAbeona Therapeutics Inc.$2.60Last price
Warrants issued as part of the 2021 public offering ($9.75, exp. December 21, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$160.0M
ABEOAbeona Therapeutics Inc.$2.60Last price
Warrants issued as part of the 2022 Private Placement Offering ($4.75, exp. November 3, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$160.0M
ABEOAbeona Therapeutics Inc.$2.60Last price
Warrants issued as part of the 2024 Loan Agreement (January Warrants, $4.07, exp. January 8, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$160.0M
ABEOAbeona Therapeutics Inc.$2.60Last price
Warrants issued as part of the 2024 Loan Agreement Amendment (July 2025 Avenue Warrants, $6.07, exp. July 18, 2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$160.0M
TONXTON Strategy Co.$2.84Last price
Legacy warrants outstanding prior to the PIPE (pre-August 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$159.0M
TONXTON Strategy Co.$2.84Last price
PIPE Pre-Funded Warrants (August 7, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$159.0M
IPHAInnate Pharma S.A. ADS$1.36Last price
BSA 2017 (share subscription warrants, Board members)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$156.8M
IPHAInnate Pharma S.A. ADS$1.36Last price
BSA 2022-1 (share subscription warrants, Board members)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$156.8M
IPHAInnate Pharma S.A. ADS$1.36Last price
BSA 2023-1 (share subscription warrants, Board members)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$156.8M
IPHAInnate Pharma S.A. ADS$1.36Last price
BSA 2025-1 (share subscription warrants, Board members)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$156.8M
MINEMayfair Gold Corp.$2.22Last price
Finders' warrants – September 16, 2025 brokered private placement ($3.30, expiring September 16, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$156.4M
RRRichtech Robotics Inc. Class B Common Stock$0.6783Last price
Common Inducement Warrants ($4.00, February 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$154.0M
RRRichtech Robotics Inc. Class B Common Stock$0.6783Last price
Placement Agent Inducement Warrants ($5.00, March 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$154.0M
RRRichtech Robotics Inc. Class B Common Stock$0.6783Last price
Placement Agent Warrants ($1.69, September 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$154.0M
RRRichtech Robotics Inc. Class B Common Stock$0.6783Last price
Public Offering Warrants ($1.35, September 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$154.0M
RRRichtech Robotics Inc. Class B Common Stock$0.6783Last price
Representative’s Warrants (IPO, $6.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$154.0M
DUOTDuos Technologies Group, Inc.$3.27Last price
Pre-funded warrants – June 18, 2026 registered direct offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$153.0M
DUOTDuos Technologies Group, Inc.$3.27Last price
Underwriter warrants (Titan) – Aug/Sep 2025 offerings, $7.20
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$153.0M
DUOTDuos Technologies Group, Inc.$3.27Last price
Underwriter warrants (Titan) – March 2, 2026 offering, $9.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$153.0M
EGANeGain Corporation$5.96Last price
JPMC Warrant (August 14, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.6M
BEBEBebe Stores, Inc.$10.08Last price
Public Warrants (included in IPO Units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
BEBEBebe Stores, Inc.$10.08Last price
Sponsor Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
BEBEBebe Stores, Inc.$10.08Last price
Underwriter Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
RAILFreightCar America, Inc.$4.61Last price
2023 Warrant (Warrant No. W-004)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
RAILFreightCar America, Inc.$4.61Last price
Replacement 2020 Warrant (Warrant No. W-005, amended and restated)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
RAILFreightCar America, Inc.$4.61Last price
Replacement 2021 Warrant (Warrant No. W-006, amended and restated)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
RAILFreightCar America, Inc.$4.61Last price
Replacement 2022 Warrant (Warrant No. W-007, amended and restated)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$151.2M
TIITitan Mining Corporation$1.50Last price
Augusta Lender Warrants (C$0.63, expiring November 1, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$149.0M
TIITitan Mining Corporation$1.50Last price
Class A Warrants (US$3.04, expiring February 4, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$149.0M
TIITitan Mining Corporation$1.50Last price
Class B Warrants (US$3.71, expiring February 4, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$149.0M
PDYNPalladyne AI Corp.$2.88Last price
2024 Concurrent Private Placement Warrants (Insider Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$148.2M
FISNDeep Fission, Inc.$2.49Last price
2025 Placement Agent Warrants ($3.00, issued 2025-09-05)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$146.9M
FISNDeep Fission, Inc.$2.49Last price
February 2026 Placement Agent Warrants ($15.00, issued 2026-02-05)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$146.9M
STROSutro Biopharma, Inc.$8.78Last price
Warrants to purchase common stock (aggregate; Oxford Finance LLC / Silicon Valley Bank loan warrants per exhibit list)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$145.0M
TARAProtara Therapeutics, Inc.$2.29Last price
April 2024 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$143.8M
TARAProtara Therapeutics, Inc.$2.29Last price
December 2024 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$143.8M
HUMAHumacyte, Inc.$0.5104Last price
Legacy Humacyte Common Stock Warrants (SVB lenders)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$142.4M
HUMAHumacyte, Inc.$0.5104Last price
Loan Agreement Warrants (Avenue) — base exercise value
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$142.4M
HUMAHumacyte, Inc.$0.5104Last price
November 2024 RDO Warrants (1,640-day tranche)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$142.4M
HUMAHumacyte, Inc.$0.5104Last price
October 2024 RDO Warrants (1,640-day tranche)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$142.4M
HUMAHumacyte, Inc.$0.5104Last price
October 2025 RDO Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$142.4M
HUMAHumacyte, Inc.$0.5104Last price
Other warrants (service agreement, May 27, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$142.4M
FUFUBitFuFu Inc. Class A Ordinary Shares$0.8099Last price
Unit Purchase Option (Chardan) - 115,000 Option Units
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.9M
FUFUBitFuFu Inc. Class A Ordinary Shares$0.8099Last price
Warrants assumed from Arisz Acquisition Corp. (public and private warrants; Nasdaq: FUFUW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.9M
ABATAmerican Battery Technology Company Common Stock$0.9701Last price
August 2024 Private Placement Series A Warrants ($1.00, Group A units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.0M
ABATAmerican Battery Technology Company Common Stock$0.9701Last price
CEO warrants granted 01/04/2025 ($0.99, Melsert)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.0M
ABATAmerican Battery Technology Company Common Stock$0.9701Last price
CEO warrants granted 02/26/2024 ($4.33, Melsert)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.0M
ABATAmerican Battery Technology Company Common Stock$0.9701Last price
CEO warrants granted 04/06/2024 ($4.33, Melsert)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.0M
ABATAmerican Battery Technology Company Common Stock$0.9701Last price
CEO warrants granted 10/04/2024 ($4.33, Melsert)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$141.0M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,058 dilution snapshots. 4,848 of 5,304 series state an exercise price and 3,365 an expiry date. 68 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.